Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
Patients with partial-onset seizures seen in community-based practices were to be included in
this therapeutic use study
- to assess the safety and tolerability of Keppra (Levetiracetam) and to confirm the
favorable safety of the drug found during clinical development
- to obtain further information about optimal dosing in daily clinical practice. Compared
to previous registration trials, the study population corresponded more closely to that
seen in daily clinical practice.